Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision label (Revision: v3.3.3) was added to the History. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:27.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry v3.3.2 and removes v3.2.0 from the list. This updates the visible revision history and reflects the latest changes to the trial record.
    Difference
    0.1%
    Check dated 2025-11-25T10:17:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The government funding notice/banner at the top of the page has been removed, and the trial record content and navigation remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-18T06:48:05.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Version history shows updates to Study Status and Recruitment Status, including changes to Contacts/Locations. These updates reflect changes in the trial's current activity and site information.
    Difference
    0.1%
    Check dated 2025-11-03T20:42:02.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.
    Difference
    13%
    Check dated 2025-10-06T04:50:54.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T02:55:48.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.